ClinicalTrials.gg
RecruitingNCT07096531Updated Jul 31, 2025

Effectiveness of Suit Therapy With Dual Task Exercises on Gross Motor Functions and Walking in Children With Diplegic Cerebral Palsy

An interventional study of Suit therapy and Suit therapy + Dual-task exercises in Suit Therapy, Dual Task Exercises and Gross Motor Functions, sponsored by Kafrelsheikh University. Recruiting at 1 site in Egypt. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2025-07-31.

Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 1 month ago, but the record still lists the study as recruiting.
  • Registered 1 year 9 months after the study started (first participant enrolled Oct 2023, registered Jul 2025).
  • Started Oct 2023; still recruiting 3 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Cerebral Palsy by Kafrelsheikh University — 9 open to participants now, 10 under way, none of them phase 3. Cerebral Palsy · Kafrelsheikh University.

Planned enrollment
8th of 12
30 · median 36
Started
2023
the only one that year
No phase
12 of 12
9 open now
Registered
11th of 12
by date

Among the 12 studies in Cerebral Palsy by Kafrelsheikh University, this one is the 8th largest by planned enrollment, is the only one that started in 2023, is one of 12 with no phase, and was the 11th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

9 of the 12 studies in Cerebral Palsy by Kafrelsheikh University are open now, in 1 country. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 9 open studies →

Where they have run

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 6 Years to 12 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Cerebral Palsy by Kafrelsheikh University, or all of them as a file.
02

Study summary

This study aims to investigate the effect of suit therapy combined with dual-task training on gross motor performance and walking abilities in children with diplegic cerebral palsy.

Read the detailed description

Cerebral palsy (CP) is a non-progressive motor impairment syndrome caused by brain defects or lesions that occur in an immature brain before, during, or within two years after birth.

Therapeutic approaches for CP include neurodevelopmental treatment, Vojta therapy, sensory integration therapy, and conductive education. Specific therapeutic strategies for CP may differ, but they all aim to improve the independence of children with CP.

Suit therapy is a relatively new and experimental form of therapy designed to help those with cerebral palsy improve muscle tone, posture, and movements.

03

Conditions studied

  • Suit Therapy
  • Dual Task Exercises
  • Gross Motor Functions
  • Walking
  • Children
  • Diplegic Cerebral Palsy

Browse trials for

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age from 6 to 12 years.
  • Both sexes.
  • A medical diagnosis of spastic diplegic CP made by pediatricians or pediatric neurologists.
  • Children with spasticity grades ranged from 1 to 2+ according to the Modified Ashworth scale (MAS).
  • Children who can sit on the chair with good balance and recognize and follow verbal orders and commands are included in both testing and training techniques.

Exclusion criteria

Exclusion Criteria:

  • They had a permanent deformity (bony or soft tissue contractures).
  • Children having visual or auditory defects.
  • Current hospitalization for urgent medical reasons.
  • Severe mental retardation.
  • Children who will undergo fewer than twelve regular sessions of physical therapy at their place will not be included in the survey.
  • Children with a history of epileptic seizure or any diagnosed cardiac or orthopedic disability that may hinder assessment methods and treatment.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    Group (A)

    Patients will receive suit therapy.

    Other: Suit therapy

  • Experimental
    Group (B)

    Patients will receive suit therapy in addition to dual-task exercises.

    Other: Suit therapy + Dual-task exercises

Interventions

  • OtherSuit therapy

    Patients will receive suit therapy.

  • OtherSuit therapy + Dual-task exercises

    Patients will receive suit therapy in addition to dual-task exercises.

06

What researchers measure

Primary outcomes

  1. Evaluation of Gross Motor Function Measure 88 (GMFM-88)

    The Gross Motor Function Measure (GMFM) 88 will be used to determine the severity of each case and to assess the child's motor performance in five dimensions: lying and rolling (17 items); sitting (20 items); crawling and kneeling (14 items); standing (13 items); and walking, running, and jumping (24 items). All items will be checked and scored before interpretation of the child's performance in each dimension. Scores of each dimension will be expressed as a percentage of the maximum scores for that dimension. The total score will be obtained by averaging the percentage scores across the five dimensions. Individual dimensions of GMFM-88 can be administered depending on the child's current level of function.

    Time frame: 3 months post-exercise

Secondary outcomes

  1. Evaluation of balance using the Pediatric Balance Scale (PBS)

    The Pediatric Balance Scale (PBS) is a standardized tool for testing balance. The items can be measured within 15 minutes and do not require specialized equipment. The Pediatric Balance Scale is a modified version of the Berg Balance Scale, used to assess functional balance skills in school-aged children. The scale consists of 14 items that are scored from 0 points (lowest function) to 4 points (highest function), with a maximum score of 56 points

    Time frame: 3 months post-exercise

07

Study locations

1 of 1 sites recruiting
  • Kafrelsheikh University
    Kafr ash Shaykh, Kafrelsheikh, Egypt
    Recruiting
    • Waleed S Althobaiti, MBBCH · ContactWalthubiti89@hotmail.com · 0536164010
    • Mohamed B Ibrahim, MD · Sub investigator
    • Nesma E Barakat, MD · Sub investigator
    • Abeer M Salamah, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Supporting information: Study protocol

Time frame: After the end of study for one year.

Access criteria: The data will be available upon a reasonable request from the corresponding author.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Sep 2025, 23 months after the start.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 23 months is above that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 24, 2025
First posted
Jul 31, 2025
StartActual
Oct 1, 2023
Primary completionEst.
Sep 30, 2025
CompletionEst.
Sep 30, 2025
Last update
Jul 31, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07096531
Responsible party
Waleed Saleh Althobaiti (B.Sc. in Physical Therapy, Faculty of Physical Therapy, Kafrelsheikh University, Kafrelsheikh, Egypt., Kafrelsheikh University) — Principal investigator
First posted
Jul 31, 2025
Start date
Oct 1, 2023
Primary completion
Sep 30, 2025 (estimated)
Completion
Sep 30, 2025 (estimated)
Last update
Jul 31, 2025

Study contacts

Waleed S Althobaiti, MBBCH
Contact
Walthubiti89@hotmail.com
0536164010

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion